Targeting vasculature in urologic tumors: mechanistic and therapeutic significance.
about
Therapeutic challenges in renal cell carcinomaTherapeutic value of quinazoline-based compounds in prostate cancer.Targeting of α(v)-integrins in stem/progenitor cells and supportive microenvironment impairs bone metastasis in human prostate cancer.Tivozanib in the treatment of renal cell carcinoma.Integrins in prostate cancer progressionBeta1 integrin cytoplasmic variants differentially regulate expression of the antiangiogenic extracellular matrix protein thrombospondin 1.Systemic therapy of kidney cancer: tyrosine kinase inhibitors, antiangiogenesis or IL-2?The role of vitamin D in cancer prevention and treatment.Vascular endothelial growth factor-targeted therapy for the treatment of renal cell carcinoma.Molecular aspects of renal cell carcinoma: a review.The role of vitamin D in cancer prevention and treatment.The VEGF pathway in lung cancer.The role of the RhoA/Rho kinase pathway in angiogenesis and its potential value in prostate cancer (Review).Efficient (18)F-labeling of large 37-amino-acid pHLIP peptide analogues and their biological evaluation.Extratumoral macrophages promote tumor and vascular growth in an orthotopic rat prostate tumor model.Profiling Prostate Cancer Therapeutic Resistance.Targeting TGF-beta in prostate cancer: therapeutic possibilities during tumor progression
P2860
Q26796702-B5840D9E-0336-4E91-BFD1-CD7F0D3B9186Q33746225-7C96B623-7954-43C9-B5D5-3080B525B919Q35042977-25288444-590E-42C6-BFBA-43403F641B8BQ36933605-58431022-186C-4051-ABE9-B5E62C8A16CEQ37182177-43ACA1F7-6819-4EDF-9E5D-FE702E0E8376Q37426688-6AC843A0-C4AF-474E-BF68-282210F33905Q37575635-B92E806C-9BE3-4034-A9F8-3E82108BE23DQ37761548-308D26D4-2650-490E-83C0-22F50427274FQ37895254-0B51D054-A7B7-41CE-AA25-20ACAE8CCED3Q37942072-DC40C549-A754-4D7C-B137-9FF37C228E7BQ38004753-63DBD19B-6DEC-47D4-857D-E14CA8F0A0A1Q38148460-CA06B83D-361D-44E4-B7EA-5203DD2FF644Q38257530-5903AC75-6324-446A-B41B-60C33FC148BEQ39316483-BF3A593D-3B22-429A-9E25-AF9F450E3CCAQ43193855-3810B0A3-7897-414B-9AE0-413B074665FFQ52644478-9D89CCAD-E424-4EF2-84FC-5453AC5552ADQ57142667-4DD00066-2C34-4E9D-94B3-4616E2193352
P2860
Targeting vasculature in urologic tumors: mechanistic and therapeutic significance.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Targeting vasculature in urologic tumors: mechanistic and therapeutic significance.
@ast
Targeting vasculature in urologic tumors: mechanistic and therapeutic significance.
@en
type
label
Targeting vasculature in urologic tumors: mechanistic and therapeutic significance.
@ast
Targeting vasculature in urologic tumors: mechanistic and therapeutic significance.
@en
prefLabel
Targeting vasculature in urologic tumors: mechanistic and therapeutic significance.
@ast
Targeting vasculature in urologic tumors: mechanistic and therapeutic significance.
@en
P2093
P2860
P356
P1476
Targeting vasculature in urologic tumors: mechanistic and therapeutic significance.
@en
P2093
A Jacqueline Ryan
Natasha Kyprianou
Shinichi Sakamoto
P2860
P304
P356
10.1002/JCB.21442
P577
2008-02-01T00:00:00Z